William Garrett Gray
2019
In 2019, William Garrett Gray earned a total compensation of $542.3K as Vice President, Finance and Accounting at Checkpoint Therapeutics, a 24% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $56,888 |
|---|---|
| Salary | $185,000 |
| Stock Awards | $292,500 |
| Other | $7,960 |
| Total | $542,348 |
Gray received $292.5K in stock awards, accounting for 54% of the total pay in 2019.
Gray also received $56.9K in non-equity incentive plan, $185K in salary and $8K in other compensation.
Rankings
In 2019, William Garrett Gray's compensation ranked 11,513th out of 13,971 executives tracked by ExecPay. In other words, Gray earned more than 17.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,513 out of 13,971 | 18th |
Division Manufacturing | 4,665 out of 5,701 | 18th |
Major group Chemicals And Allied Products | 1,838 out of 2,200 | 17th |
Industry group Drugs | 1,582 out of 1,886 | 16th |
Industry Pharmaceutical Preparations | 1,170 out of 1,398 | 16th |
Source: SEC filing on April 24, 2020.
Gray's colleagues
We found one more compensation record of an executive who worked with William Garrett Gray at Checkpoint Therapeutics in 2019.
2019
James Oliviero
Checkpoint Therapeutics
Chief Executive Officer
News
Checkpoint Therapeutics CEO James Oliviero's 2021 pay stays at $2.3M
April 29, 2022
Checkpoint Therapeutics CEO James Oliviero's 2020 pay slips 1% to $2.3M
April 30, 2021
Checkpoint Therapeutics CEO James Oliviero's 2019 pay rises 8% to $2.3M
April 24, 2020
Checkpoint Therapeutics CEO James Oliviero's 2018 pay jumps 230% to $2.1M
April 30, 2019